System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Faouzi Saliba is an expert in Hepatology at Hôpital Paul-Brousse (France). As of October 2026, ScienceLeadR ranks Faouzi Saliba in the top 1% of experts worldwide for Hepatic Insufficiency, Liver Failure and Liver Transplantation. Faouzi Saliba has authored 430 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 3 of them ongoing. SLR score: 1,451 (community average: 125). How the SLR is computed.

LeadR Profile

Faouzi Saliba Hôpital Paul-Brousse France
1 451 ScienceLeadR Reputation 1451

Unlock

Register Login
Network Map

Hepatology

Subspecialties: Transplantation - Gastroenterology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026
Source: PubMed

Hôpital Paul-Brousse

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 430

Citations

Citations: 23 149 1st author: 59 Last author: 45 Unique author: 8

Main journals

J Hepatol 106
Transplantation 39
Liver Transpl 24
Hepatology 16
Transplant Proc 12

Best Journals

J Hepatol 16
Lancet 2
Lancet Gastroenterol Hepatol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Negative-pressure ICU rooms and pulmonary aspergillosis: room conversion matters.
PMID 42864668 — pulmonary aspergillosis, aspergillosis		Crit Care20260
Guidelines 2025: perioperative management of adult patients undergoing liver resection.
PMID 42567152 — anesthesia, liver		Anaesth Crit Care Pain Med20260
Right (H145678) and Left (H123458) 6-Segmentectomies for Malignant Liver Tumors: A Retrospective Analysis of 237 Cases Using Contemporary Surgery Quality Indicators.
PMID 42522084 — neoplasms, mastectomy, segmental, liver, general surgery, cholangiocarcinoma, survival rate		Ann Surg20260
Corrigendum to "Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts" [J Hepatol 85 (2026) 91-105].
PMID 42502052 — liver diseases, acute-on-chronic liver failure, liver, liver failure		J Hepatol Top journal20260
Everolimus and de novo malignancies after liver transplantation: a Nationwide Emulated Trial Using Real-World Data.
PMID 42413767 — liver transplantation, incidence, neoplasms, tacrolimus, liver, everolimus, transplants, research, immunosuppression therapy, transplantation		JHEP Rep20260

Clinical Studies 19

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 7
Phase 3 6
Phase 4 3
Phase 2 2
Phase 2/Phase 3 1

By status:

Completed 12
Recruiting 3
Terminated 2
Unknown 2

By type:

Interventional 16
Observational 3

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 2
multicentric5to9 1
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Evaluation of the benefits of Administering immunosuppressive drugs as Single daily doses over the first Year after liver transplantation
2023-506601-19-00 — liver transplantation, incidence, pharmaceutical preparations, treatment failure, tacrolimus, liver, transplants, therapeutics, transplantation		Phase 4Recruiting2025
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
NCT06354179 — quality of life, liver transplantation, safety, blood, pharmaceutical preparations, adrenal cortex hormones, tacrolimus, liver, transplants, therapeutics, immunosuppression therapy, transplantation, mycophenolic acid		Phase 4Recruiting2025
Clearance of Vasoactive Metabolites With Blood Purification
NCT06109142 — pilot projects, pilots, blood, shock, septic, renin, angiotensins, sepsis, critical illness, therapeutics, membranes, renin-angiotensin system, hemodynamics		N/ARecruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS